| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.14 | 0.009 |